Bill > LD480

This bill requires Maine's Department of Health and Human Services to provide MaineCare (Maine's Medicaid program) coverage for specific weight loss medications known as glucagon-like peptide-1 (GLP-1) receptor agonists that have been approved by the federal Food and Drug Administration (FDA) for obesity treatment. The coverage comes with two key restrictions: the medications must be prescribed exclusively by either a primary care provider or a bariatric specialist, and patients must obtain prior authorization before the medication can be reimbursed. GLP-1 receptor agonists are a class of medications originally developed to treat type 2 diabetes that have shown significant effectiveness in supporting weight loss, and this bill aims to make these potentially costly medications more accessible to MaineCare recipients who might benefit from them in managing obesity.

Health and Social Services

https://legislature.maine.gov/legis/bills/display_ps.asp?LD=480&snum=132